Gender differences in secondary prevention of coronary heart disease: Reasons to worry or not?

Scandinavian Journal of Primary Health Care

Volumn 21, Issue 1, 2003, Pages 37-42

  Nilsson, Peter ^a   Brandström, Hans ^b   Lingfors, Hans ^c   Erhardt, Leif ^a   Hedbäck, Bo ^d   Israelsson, Bo ^a   Sjöberg, Gunilla ^e  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Prim Hlt Care Ctr Grabo Terranova   (Sweden)

^c Primary Health Care Centre   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e Res/Devmt Unit for the Elderly   (Sweden)

Author keywords

Coronary heart disease; Hypertension; Lifestyle; Lipids; Risk; Secondary prevention

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; FEMALE; HEALTH PROGRAM; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; QUALITY CONTROL; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SELF REPORT; SEX DIFFERENCE;

CORONARY DISEASE; FEMALE; HEALTH BEHAVIOR; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HUMANS; HYPERTENSION; LIFE STYLE; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS; RISK REDUCTION BEHAVIOR; SELF EFFICACY; SEX FACTORS; SWEDEN;

EID: 0037356566     PISSN: 02813432     EISSN: None     Source Type: Journal    
DOI: 10.1080/02813430310000546     Document Type: Article

References (25)

1. Prevention of coronary risk in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Summary of recommendations. Eur Heart J 1998;19:1434-503.
2. Nationella riktlinjer för behandling av kranskärlssjukdom (National guidelines for the treatment of coronary heart disease). Stockholm: Socialstyrelsen, 2001.
3. Eurospire I and II Group. EUROSPIRE: a European Society of Cardiology survey of secondary prevention of coronary heart disease, principal results. Eur Heart J 1997;18:1569-82.
4. Eurospire I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROSPIRE I and II in nine countries. Lancet 2001;357:995-1001.
5. Hippisley-Cox J, Pringle M, Crown N, Meal A, Wynn A. Sex inequalities in ischemic heart disease in general practice: cross sectional study. BMJ 2001;322:832-4.
6. Majeed FA, Cook DG. Age and sex differences in the management of ischaemic heart disease. Public Health 1996;110:7-12.
7. Attebring MF, Hartford M, Berndt AK, Herlitz J. Has interest in secondary prevention increased among physicians after the 4S study? Scand Cardiovasc J 2000;34:164-7.
8. Svilaas A, Thoresen M, Kristoffersen JE, Hjartaaker J, Westheim A. How well are patients with atherosclerotic disease treated? Secondary prevention in primary care. Scand J Prim Health Care 2000;18:232-6.
9. Davis JE, McBride PE, Bobula JA. Improving prevention in primary care: physicians, patients, and process. J Fam Pract 1992;35:385-7.
10. Thiru K, Gray J, Majeed A. Management of ischaemic heart disease in primary care: towards better practice. STaRNet. South Thames Region Network. J Public Health Med 1999;21:179-84.
11. Gray J, Majeed A, Kerry S, Rowlands G. Identifying patients with ischaemic heart disease in general practice: cross sectional study of paper and computerised medical records. BMJ 2000;321:548-50.
12. Feder G, Griffiths C, Eldridge S, Spence M. Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial. BMJ 1999;318:1522-6.
13. Jolly K, Bradley F, Sharp S, Smith H, Thompson S, Kinmonth AL, et al. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. BMJ 1999;318:706-11.
14. Campbell NC, Ritchie LD, Thain J, Deans HG, Rawles JM, Squair JL. Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care. Heart 1998;80:447-52.
15. McCallum AK, Whincup PH, Morris RW, Thomson A, Walker M, Ebrahim S. Aspirin use in middle-aged men with cardiovascular disease: are opportunities being missed? Br J Gen Pract 1997;47:417-21.
16. Moher M, Yudkin P, Wright L, Turner R, Fuller A, Schofield T, et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention in primary care. BMJ 2001;322:1338.
17. Erhardt L, Nilsson P. Quality assurance of secondary prevention - a solution to better implementation of guidelines. Scand Cardiovasc J 1999;33:3-4.
18. Brandström H, Erhardt L, Hedbäck B, Israelsson B, Lingfors H, Nilsson P, et al. Quality assurance of secondary prevention in coronary artery disease. Ongoing project offers prospective for improved treatment. Läkartidningen 2001;98:4846-52.
19. Danielsson B, Aberg H. Hyperlipidaemia - management and views amongst physicians in general practice, in occupational health care and in internal medicine. J Intern Med 1993;234:411-6.
20. Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001;285:430-6.
21. Carlsson R. Serum cholesterol, lifestyle, working capacity and quality of life in patients with coronary artery disease. Experiences from a hospital-based secondary prevention programme. Scand Cardiovasc J 1998;50 (Suppl):1-20.
22. Lisspers J, Hofman-Bang C, Nordlander R, Ryden L, Sundin O, Ohman A, et al. Multifactorial evaluation of a program for lifestyle behavior change in rehabilitation and secondary prevention of coronary artery disease. Scand Cardiovasc J 1999;33:9-16.
23. Brady AJ, Oliver MA, Pittard JB. Secondary prevention in 24,431 patients with coronary heart disease: survey in primary care. BMJ 2001;322:1463.
24. McAlister FA, Lawson FM, Teo KK, Armstrong PW. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ 2001;323:957-62.
25. Kahan T, Wändell P. Risk factors in established coronary heart disease: evaluation of a secondary prevention programme. J Cardiovasc Risk 2001;8:73-80.